A novel series of muscarinic receptor ligands of the hexamethonio-type was prepared which contained, on one side, the phthalimidopropane or 1,8-naphthalimido-2,2-dimethylpropane moiety typical for subtype selective allosteric antagonists and, on the other, the acetylenic fragment typical for the nonselective orthosteric muscarinic agonists oxotremorine, oxotremorine-M, and related muscarinic agonists. Binding experiments in M2 receptors using [3H]N-methylscopolamine as an orthosteric probe proved an allosteric action of both groups of hybrids, 7a-10a and 8b-10b. The difference in activity between a-group and b-group hybrids corresponded with the activity difference between the allosteric parent compounds. In M1-M3 muscarinic isolated organ preparations, most of the hybrids behaved as subtype selective antagonists. [35S]GTPgammaS binding assays using human M2 receptors overexpressed in CHO cells revealed that a weak intrinsic efficacy was preserved in 8b-10b. Thus, attaching muscarinic allosteric antagonist moieties to orthosteric muscarinic agonists may lead to hybrid compounds in which functions of both components are mixed. J. Med. Chem. 2006, 49, 366-372
Design, Synthesis and Action of Oxotremorine-related Hybrid-type Allosteric Modulators of Muscarinic Acetylcholine Receptors / T., Disingrini; M., Muth; C., Dallanoce; Barocelli, Elisabetta; Bertoni, Simona; K., Kellershohn; K., Mohr; M., DE AMICI; U., Holzgrabe. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 49:(2006), pp. 366-372. [10.1021/jm050769s]
Design, Synthesis and Action of Oxotremorine-related Hybrid-type Allosteric Modulators of Muscarinic Acetylcholine Receptors
BAROCELLI, Elisabetta;BERTONI, Simona;
2006-01-01
Abstract
A novel series of muscarinic receptor ligands of the hexamethonio-type was prepared which contained, on one side, the phthalimidopropane or 1,8-naphthalimido-2,2-dimethylpropane moiety typical for subtype selective allosteric antagonists and, on the other, the acetylenic fragment typical for the nonselective orthosteric muscarinic agonists oxotremorine, oxotremorine-M, and related muscarinic agonists. Binding experiments in M2 receptors using [3H]N-methylscopolamine as an orthosteric probe proved an allosteric action of both groups of hybrids, 7a-10a and 8b-10b. The difference in activity between a-group and b-group hybrids corresponded with the activity difference between the allosteric parent compounds. In M1-M3 muscarinic isolated organ preparations, most of the hybrids behaved as subtype selective antagonists. [35S]GTPgammaS binding assays using human M2 receptors overexpressed in CHO cells revealed that a weak intrinsic efficacy was preserved in 8b-10b. Thus, attaching muscarinic allosteric antagonist moieties to orthosteric muscarinic agonists may lead to hybrid compounds in which functions of both components are mixed. J. Med. Chem. 2006, 49, 366-372File | Dimensione | Formato | |
---|---|---|---|
AbstJMedChem2006.pdf
non disponibili
Tipologia:
Abstract
Licenza:
Creative commons
Dimensione
46.76 kB
Formato
Adobe PDF
|
46.76 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
JMedChem2006SB.pdf
non disponibili
Tipologia:
Documento in Post-print
Licenza:
Creative commons
Dimensione
543.67 kB
Formato
Adobe PDF
|
543.67 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.